Excerpted and adapted from:
Matcham F, Galloway J, Hotopf, et al. The impact of targeted rheumatoid arthritis pharmacologic treatment on mental health. Arthritis Rheumatol. 2018 Sep;70(9):1377–1391.
Related Articles
Pharmaceutical Care Models, Tools for Treating Patients with Rheumatoid Arthritis
Rheumatoid arthritis (RA) can be defined as a chronic autoimmune systemic inflammatory condition characterized by symmetrical polyarthritis. Typically, patients present with pain, stiffness and warmth of the affected joints. The condition can result in extra-articular features, adding to disability, and may eventually lead to premature death, especially if not treated early and appropriately.1,2 Over the…
Pain in Rheumatoid Arthritis
Out from the shadow of inflammation
Depression in Rheumatoid Arthritis
Examining the psychological and health-related comorbidities of rheumatoid arthritis patients with depression
Physical Activity, Exercise Can Benefit Patients with RA
While medical advances in rheumatoid arthritis (RA) have led to improvements in disease control and quality of life for patients worldwide, the rate for stable remission remains low.1 Management of RA symptoms is traditionally accomplished through a combination of medications and nonpharmacological interventions.2 This approach can prevent the development of secondary adverse health outcomes. Two…